Giovanni A Fontana
Overview
Explore the profile of Giovanni A Fontana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorano A, Fumagalli C, Cinelli E, Birring S, Fontana G, Lavorini F
Respir Med
. 2024 Apr;
227:107642.
PMID: 38670318
Objective: To implement subjective methods for measuring the impact of chronic cough on patients' daily life, including an Italian version of the symptom-specific, health status measure for patients with chronic...
2.
Lavorini F, Bernacchi G, Fumagalli C, Noale M, Maggi S, Mutolo D, et al.
EClinicalMedicine
. 2023 Mar;
57:101869.
PMID: 36874394
Background: Recently we identified in patients with chronic cough a sensory dysregulation via which the urge-to-cough (UTC) or coughing are evoked mechanically from "somatic points for cough" (SPCs) in the...
3.
Mannini C, Bernacchi G, Bonti V, Cinelli E, Mutolo D, Fontana G, et al.
Respir Med
. 2022 Jul;
200:106929.
PMID: 35853267
In patients with chronic cough and age-matched control subjects, we attempted to evoke coughing and/or an urge to cough (UTC) by finger pressure along the sternocleidomastoid and sternum, on the...
4.
Cameli P, Bargagli E, Bergantini L, DAlessandro M, Pieroni M, Fontana G, et al.
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32867116
Fractional exhaled nitric oxide (FeNO) is a well-known and widely accepted biomarker of airways inflammation that can be useful in the therapeutic management, and adherence to inhalation therapy control, in...
5.
Lavorini F, Fontana G
Pulm Pharmacol Ther
. 2017 Jun;
47:56-58.
PMID: 28564586
No abstract available.
6.
Lavorini F, Spina D, Walker M, Franciosi L, Page C, Fontana G
Pulm Pharmacol Ther
. 2016 Aug;
40:91-4.
PMID: 27538683
Background: Cough is a common presenting symptom in patients with idiopathic interstitial pneumonia (IIP); it is often disabling, and lacks effective treatment. Studies in animals suggest that carcainium chloride, a...
7.
Lavorini F, Mannini C, Chellini E, Fontana G
Drugs Aging
. 2016 May;
33(7):461-73.
PMID: 27216613
Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled medications are the mainstay of pharmacological treatment of COPD, and are typically administered by handheld inhalers, such as pressurised...
8.
Lavorini F, Chellini E, Bigazzi F, Surrenti E, Fontana G
Chest
. 2016 Feb;
149(6):1467-72.
PMID: 26836929
Background: Patients with deflation cough (DC), the cough-like expulsive effort(s) evoked by maximal lung emptying during a slow vital capacity maneuver, also present symptoms of gastroesophageal reflux. DC can be...
9.
Chellini E, Lavorini F, Campi G, Mannini C, Fontana G
Pulm Pharmacol Ther
. 2015 May;
33:11-4.
PMID: 25986314
Background: Deflation cough (DC), i.e. the cough-like expiratory expulsive efforts evoked by maximal lung emptying, is partially inhibited by prior intake of an antacid. We wished to compare the effects...
10.
Lavorini F, Chellini E, Innocenti M, Campi G, Egan C, Mogavero S, et al.
Cough
. 2015 Jan;
10(1):7.
PMID: 25632296
Background: Persistent dry cough is a well known unwanted effect of Angiotensin-Converting Enzyme inhibitors (ACE-i). Animal studies have shown that the ACE-i zofenopril has a less tussigenic effect compared to...